Evidence for the activation of blood complement in Sephadex beads-induced lung inflammation in guinea pigs

Inflammation Research

Volumn 48, Issue 7, 1999, Pages 386-392

  Blain, J F ^a   Maghni, K ^a   Pelletier, S ^a   Sirois, P ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Anaphylatoxin; Complement; Eosinophils; Non immunologic stimulus

Indexed keywords

ALBUMIN; APROTININ; BETA GLUCURONIDASE; CITRATE SODIUM; COMPLEMENT; HISTAMINE; PEROXIDASE; PROTEIN; SEPHADEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; COLORIMETRY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; EOSINOPHIL; GUINEA PIG; INFLAMMATION; LEUKOCYTE; LUNG LAVAGE; NONHUMAN; PNEUMONIA;

ANIMALS; APROTININ; COMPLEMENT ACTIVATION; DEXTRANS; GUINEA PIGS; PNEUMONIA;

EID: 0032814134     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050476     Document Type: Article

References (34)

1. Castro FF, Schmitz-Schumann M, Rother U, Kirschfink M. Complement activation by house dust reduced reactivity of serum complement in patients with bronchial asthma. Int Arch Allergy Immun 1991; 96: 305-10.
2. Robbins RA, Nelson KJ, Gossman GL, Koyama S, Rennard SI. Complement activation by cigarette smoke. Am J Physiol 1991; 260: L254-9.
3. Videm V, Mollnes TE. Human complement activation by polygeline and dextran 70. Scand J Immunol 1994; 39: 314-20.
4. Kay AB, Shin HS, Austen KF. Selective attraction of eosinophils and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a fragment cleaved from the fifth component of complement (C5a). Immunology 1973; 24: 969-76.
5. Hartmann K, Henz BM, Kruger-Krasagakes S, Kohl J, Burger R, Guhl S, et al. C3a and C5a stimulate chemotaxis of human mast cells. Blood 1997; 89: 2863-70.
6. Jose PJ, Moss IK, Maini RN, Williams TJ. Measurements of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase. Ann Rheum Dis 1990; 49: 747-52.
7. Eisner J, Oppermann M, Czech W, Dobos G, Schopf E, Norgauer J, et al. C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils. Eur J Immunol 1994; 24: 518-22.
8. Daffern PJ, Pfeifer PH, Ember JA, Hugli TE. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 1995; 181: 2119-27.
9. Maghni K, Lanoue C, Cloutier S, Cristol JP, Cadieux A, Sirois P. Sephadex-induced bronchial hyperreactivity and airway eosinophilia. Pharmacologist 1992; 34: 358.
10. Maghni K, Blanchette F, Sirois P. Induction of lung eosinophilia and neutrophilia in guinea pigs following injection of Sephadex beads. Inflammation 1993; 17: 537-50.
11. Carreno MP, Labarre D, Jozefowicz M, Kazatchkine MD. The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives. Mol Immunol 1988; 25: 165-71.
12. Mauzac M, Aubert N, Jozefonvicz J. Antithrombic activity of some polysaccharide resins. Biomaterials 1982; 3: 221-4.
13. Servais G, Walmagh J, Duchateau J. Simple quantitative haemolytic microassay for determination of complement alternative pathway activation (AP50). J Immunol Methods 1991; 140: 93-100.
14. Klerx JPAM, Beukelman CJ, Van Dijk H, Willers JMN. Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum. J Immunol Methods 1983; 63: 215-20.
15. Strath M, Warren DJ, Sanderson CJ. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. J Immunol Methods 1985; 83: 209-15.
16. White SR, Kulp GV, Spaethe SM, Van Alstyne E, Leff AR. A kinetic assay for eosinophil peroxidase activity in eosinophils and eosinophil conditioned media. J Immunol Methods 1991; 144: 257-63.
17. Walls AF, Rhee YK, Gould DJ, Walters C, Robinson MK, Church MK, et al. Inflammatory mediators and the cellular infiltration of the lungs in a guinea pig model of the late asthmatic reaction. Lung 1991; 169: 227-40.
18. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
19. Doumas BT, Watson WA, Biggs HG. Albumin standards and the measurements of serum albumin with bromocresol green. Clin Chim Acta 1971; 31: 87-96.
20. Marwaha RK, Johnson BF, Wright CE. Simple stability-indicating assay for histamine solutions. Am J Hosp Pharm 1985; 42: 1568-71.
21. Alper CA, Rosen FS. Studies of the in vivo behavior of human C'3 in normal subjects and patients. J Clin Invest 1967; 46: 2021-34.
22. Carpenter CB, Ruddy S, Shehadeh IH, Muller-Eberhard HJ, Merril JP, Austen KF. Complement metabolism in man: Hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary angioedema (HAE). J Clin Invest 1969; 48: 1495-505.
23. Ziegler JB, Rosen FS, Alper CA, Grupe W, Lepow IH. Metabolism of properdin in normal subjects and patients with renal disease. J Clin Invest 1975; 56: 761-7.
24. Kazatchkine MD, Nydegger UE. The human alternative complement pathway: biology and immunopathology of activation and regulation. Prog Allergy 1982; 30: 193-234.
25. Maillet F, Carreno MP, Labarre D, Jozefowicz M, Kazatchkine MD. Carboxymethylation suppresses the ability of Sephadex to activate the human alternative pathway by facilitating inactivation of bound C3b with h and I. Complement 1987; 4: 188.
26. Carreno MP, Maillet F, Labarre D, Jozefowicz M, Kazatchkine MD. Specific antibodies enhance Sephadex-induced activation of the alternative complement pathway in human serum. Biomaterials 1998; 9: 514-8.
27. Chenoweth DE. Complement activation during hemodialysis: clinical observations, proposed mechanisms, and theoritical implications. Artif Organs 1984; 8: 281-90.
28. Austen KF. Hageman-factor-dependant coagulation, fibrinolysis, and kinin generation. Transplant Proc 1974; 6: 39-45.
29. Toufik J, Labarre D. Relationship between reduction of complement activation by polysaccharide surfaces bearing diethylaminoethyl groups and their degree of substitution. Biomaterials 1995; 16: 1081-8.
30. Siebeck M, Fink E, Weipert J, Jochum M, Fritz H, Spannagl M, et al. Inhibition of plasma kallikrein with aprotinin in porcine endotoxic shock. J Trauma 1993; 34: 193-8.
31. Bhoola KD, Figueroa CD, Worthy K. Inhibition of plasma kallikrein with aprotinin in porcine endotoxic shock. Pharmacol Rev 1992; 44: 1-80.
32. Ohlsson F, Balldin G, Lasson A. Trypsin-induced release of bradykinin and of C3 fragments in man: clinical and experimental studies on the protective role of α2-macroglobulin and aprotinin. Adv Exp Med Biol 1983; 156: 1083-90.
33. Lasson A, Ohlsson K. On the potential role of trypsin and trypsin inhibitors in acute pancreatitis. Adv Exp Med Biol 1984; 167: 477-87.
34. Mayer MM. Experimental Immunochemistry. In: Kabat EA, Mayer MM, editors. Illinois: Thomas Springfield, 1961: 133.